Thursday 6 October 2016

Sarepta Therapeutics Inc. (SRPT) -Summit Therapeutics PLC (ADR) (SMMT) Deal Is "Low Risk, High Reward": Wedbush

Sarepta Therapeutics Inc. (SRPT) -Summit Therapeutics PLC (ADR) (SMMT) Deal Is "Low Risk, High Reward": Wedbush: "Sarepta Therapeutics Inc. (NASDAQ:SRPT) announced on Tuesday, a partnership deal with London-based Summit Therapeutics PLC (ADR) (NASDAQ:SMMT), for the development of drugs to treat Duchenne muscular dystrophy. As part of the deal, Sarepta will use its expertise to help develop Summit’s utrophin modulator pipeline and its key experimental DMD drug ezutromid in exchange for its European rights and a Latin America option. "



'via Blog this'